Immunovia announces executive management team changes to accelerate execution of strategic priorities
LUND, SWEDEN – Immunovia AB (Nasdaq Stockholm: IMMNOV) today announced changes to its executive management team to accelerate the execution of its strategic priorities. The new executive management team will be focused on delivering the next phase of Immunovia’s strategy and commercial growth. As of 1 November, the executive management team will be CEO & President Philipp Mathieu, CFO Karin Almqvist Liwendahl and CEO of Immunovia’s US subsidiary Immunovia Inc. Jeff Borcherding. In addition, a new Chief Operating Officer role will be added to the executive team during the first